Shares of Moderna (NASDAQ: MRNA) climbed 6.2% on Tuesday on a bevy of good news for the biotechnology company.
Swiss health regulators authorized Moderna's COVID-19 vaccine for use in the country. The Swiss Federal Government subsequently ordered 7.5 million doses of the vaccine, with the first deliveries expected to start later this month.
Moderna's stock popped on Tuesday after several promising developments. Image source: Getty Images.
Source Fool.com